BioSpace News Archive

BiondVax Universal Flu Vaccine Patent Granted in India

The patent belongs to BiondVax’s portfolio family titled “Multimeric Multi-Epitope Influenza Vaccines” and has now been granted in over 30 countries.

January 2, 2018
·
3 min read
Cannabics Pharma Files an International Patent Application on Methods for Testing and Predicting Therapeutic Effectiveness of Cannabinoids for Cancer Patients

Cannabics Pharmaceuticals announced today that it has filed an international patent application with the PCT authorities on methods for testing which cannabinoids or combinations of cannabinoids are likely be effective in individual patients.

January 2, 2018
·
2 min read
Business

Merz Names Terri L. Phillips, M.D., Vice President and Head of Global Medical Affairs

Merz today announced that Terri L. Phillips, M.D., F.A.A.P., has been named Vice President and Head of Global Medical Affairs, effective January 2, 2018.

January 2, 2018
·
4 min read
Business

Allurion Technologies Announces New Roles Within Its Leadership Team And Senior Management Hires

Dr. Shantanu Gaur will serve as Chief Executive Officer effective January 1, 2018.

January 2, 2018
·
5 min read
Business

Generex Confirms Receipt of $700,000 USD License Fee from Shenzhen BioScien Pharmaceuticals

The purpose of the Agreement is to develop and commercialize the Antigen Express AE37 immunotherapeutic vaccine for prostate cancer in the People’s Republic of China (including Taiwan, Hong Kong, and Macau).

January 2, 2018
·
4 min read
A*STAR’s Genome Institute of Singapore (GIS) Release: New Algorithm Predicts Treatment Targets for Cancer Using ‘Wisdom of the Crowd’

Singapore scientists develop intelligent system that sifts through massive genetic datasets to pinpoint targets for cancer treatment

January 2, 2018
·
5 min read
ASLAN Pharma’s Abstract on Varlitinib Wins Best Poster at ESMO Asia 2017

ASLAN Pharma today announced that an abstract presented at ESMO Asia 2017 on data from its Phase 2 clinical trial of varlitinib in metastatic HER2-positive breast cancer patients won the Best Poster Award in the breast cancer, metastatic category.

January 2, 2018
·
2 min read
Business

Predictive Technology Group Appoints Dr. Michael Dey To Board Of Directors

In addition to serving as a PRED Board Member, Dr. Dey will continue as Chief Executive Officer of Predicitive Therapeutics, Inc., a wholly owned subsidiary of PRED.

January 2, 2018
·
3 min read
Policy

Cascadian Therapeutics Receives Pediatric Investigation Plan Waiver From the European Medicines Agency

This removes the requirement for pediatric clinical studies to support tucatinib market authorization application for treatment of metastatic breast cancer in Europe.

January 2, 2018
·
4 min read
Recipharm Acquires Remaining Shares in Nitin Lifesciences Ltd

Recipharm today announces that it has reached an agreement to acquire the remaining 26 per cent of the shares of Nitin Lifesciences Limited which were owned by members of the founding Sobti family.

January 2, 2018
·
2 min read